Speaker
VP, Quantitative Pharmacology, Bicycle Therapeutics plc
Hongmei Xu, VP, Quantitative Pharmacology at Bicycle Therapeutics plc, is speaking at 2nd Model-Informed Drug Development Summit (Boston, United States of America, 17–19 Nov 2026) in the session “Optimizing Bicycle Drug Conjugate Dosage Using Exposure-Response Data”.
17–19 Nov 2026Boston, United States of America
Division Director, US Food & Drug Administration (FDA)
Associate Director of Pharmacometrics, Astellas Pharma
Associate Director - Clinical & Quantitative Pharmacology, Vertex Pharmaceuticals
Associate Vice President of Biostatistics, Eli Lilly & Co.
Senior Fellow, Genentech
Senior Scientist - Clinical Pharmacology & Quantitative Science, Genmab
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Hongmei Xu, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].